Robert Løvsletten Smith

18PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersClinical pharmacology and therapeuticsCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 14, 2026
Effect of Fluvoxamine Comedication on the Formation of Clozapine Metabolites Associated With Clinical Effect or Toxicity in Smoking and Nonsmoking Patients.

|Apr 18, 2024
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data.

Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell

|Feb 22, 2024
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine.

Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset

|Jul 13, 2023
Impact of age, sex and cytochrome P450 genotype on quetiapine and N-desalkylquetiapine serum concentrations: A study based on real-world data from 8118 patients.

Vigdis Solhaug, Marit Tveito, Ragnhild Birkeland Waade

|Mar 24, 2023
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism.

Birgit M Wollmann, Robert L Smith, Marianne Kristiansen Kringen

|Feb 28, 2023
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data.

Robert Løvsletten Smith, Espen Molden, Jean-Paul Bernard

Pageof 3

Frequent Collaborators

18 joint publications

Espen Molden

5 joint publications

Marianne Kristiansen Kringen

5 joint publications

Kevin S O'Connell

4 joint publications

Ole A Andreassen